These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
343 related articles for article (PubMed ID: 15479893)
1. Thrombophilic factors are not the leading cause of thrombosis in Behçet's disease. Leiba M; Seligsohn U; Sidi Y; Harats D; Sela BA; Griffin JH; Livneh A; Rosenberg N; Gelernter I; Gur H; Ehrenfeld M Ann Rheum Dis; 2004 Nov; 63(11):1445-9. PubMed ID: 15479893 [TBL] [Abstract][Full Text] [Related]
2. Thrombophilic risk factors and homocysteine levels in Behçet's disease in eastern Spain and their association with thrombotic events. Ricart JM; Vayá A; Todolí J; Calvo J; Villa P; Estellés A; España F; Santaolaria M; Corella D; Aznar J Thromb Haemost; 2006 Apr; 95(4):618-24. PubMed ID: 16601831 [TBL] [Abstract][Full Text] [Related]
3. Endothelial cell activation and hypercoagulability in ocular Behçet's disease. Probst K; Fijnheer R; Rothova A Am J Ophthalmol; 2004 May; 137(5):850-7. PubMed ID: 15126149 [TBL] [Abstract][Full Text] [Related]
4. Are patients with thrombophilia and previous venous thromboembolism at higher risk to arterial thrombosis? Linnemann B; Schindewolf M; Zgouras D; Erbe M; Jarosch-Preusche M; Lindhoff-Last E Thromb Res; 2008; 121(6):743-50. PubMed ID: 17804043 [TBL] [Abstract][Full Text] [Related]
5. Activated protein C levels in Behçet's disease and risk of venous thrombosis. Navarro S; Ricart JM; Medina P; Vayá A; Villa P; Todolí J; Estellés A; Micó ML; Aznar J; España F Br J Haematol; 2004 Aug; 126(4):550-6. PubMed ID: 15287949 [TBL] [Abstract][Full Text] [Related]
6. Vascular involvement in Behçet's disease: relation with thrombophilic factors, coagulation activation, and thrombomodulin. Espinosa G; Font J; Tàssies D; Vidaller A; Deulofeu R; López-Soto A; Cervera R; Ordinas A; Ingelmo M; Reverter JC Am J Med; 2002 Jan; 112(1):37-43. PubMed ID: 11812405 [TBL] [Abstract][Full Text] [Related]
7. [Activated protein C resistance in Behçet disease]. Guermazi S; M'Rad S; Lamloum M; Houman MH; Hamza M; Ben Dridi M; Miled M; Dellagi K Pathol Biol (Paris); 1998 Dec; 46(10):791-5. PubMed ID: 9922996 [TBL] [Abstract][Full Text] [Related]
8. [Type I antithrombin deficiency as a cause of arterial and venous thrombosis in a family with severe thrombophilia]. Tóth O; Dávid M; Habon T; Nagy A; Keszthelyi Z; Kovács N; Losonczy H Orv Hetil; 2005 Oct; 146(41):2121-5. PubMed ID: 16304806 [TBL] [Abstract][Full Text] [Related]
9. Factor V G1691A, prothrombin G20210A and methylenetetrahydrofolate reductase polymorphism C677T are not associated with coronary artery disease and type 2 diabetes mellitus in western Iran. Rahimi Z; Nomani H; Mozafari H; Vaisi-Raygani A; Madani H; Malek-Khosravi S; Parsian A Blood Coagul Fibrinolysis; 2009 Jun; 20(4):252-6. PubMed ID: 19349859 [TBL] [Abstract][Full Text] [Related]
10. Thrombophilia in young patients with acute myocardial infarction. Celik M; Altintas A; Celik Y; Karabulut A; Ayyildiz O Saudi Med J; 2008 Jan; 29(1):48-54. PubMed ID: 18176672 [TBL] [Abstract][Full Text] [Related]
11. AB0 blood group and risk of venous or arterial thrombosis in carriers of factor V Leiden or prothrombin G20210A polymorphisms. Miñano A; Ordóñez A; España F; González-Porras JR; Lecumberri R; Fontcuberta J; Llamas P; Marín F; Estellés A; Alberca I; Vicente V; Corral J Haematologica; 2008 May; 93(5):729-34. PubMed ID: 18387978 [TBL] [Abstract][Full Text] [Related]
13. No association between the common MTHFR 677C->T polymorphism and venous thrombosis: results from the MEGA study. Bezemer ID; Doggen CJ; Vos HL; Rosendaal FR Arch Intern Med; 2007 Mar; 167(5):497-501. PubMed ID: 17353498 [TBL] [Abstract][Full Text] [Related]
14. Apolipoprotein E polymorphism and lipoprotein compositions in patients with Behçet's disease. Tursen U; Eskandari G; Kaya TI; Tamer L; Ikizoglu G; Atik U Int J Dermatol; 2004 Dec; 43(12):900-3. PubMed ID: 15569012 [TBL] [Abstract][Full Text] [Related]
15. Homocysteine: an activity marker in Behçet's disease? Sarican T; Ayabakan H; Turkmen S; Kalaslioglu V; Baran F; Yenice N J Dermatol Sci; 2007 Feb; 45(2):121-6. PubMed ID: 17182219 [TBL] [Abstract][Full Text] [Related]
17. Thrombophilic genotypes, natural anticoagulants, and plasma homocysteine in myeloproliferative disorders: relationship with splanchnic vein thrombosis and arterial disease. Amitrano L; Guardascione MA; Ames PR; Margaglione M; Antinolfi I; Iannaccone L; Annunziata M; Ferrara F; Brancaccio V; Balzano A Am J Hematol; 2003 Feb; 72(2):75-81. PubMed ID: 12555209 [TBL] [Abstract][Full Text] [Related]
18. The prevalence of factor V (G1691A), MTHFR (C677T) and PT (G20210A) gene mutations in arterial thrombosis. Ozmen F; Ozmen MM; Ozalp N; Akar N Ulus Travma Acil Cerrahi Derg; 2009 Mar; 15(2):113-9. PubMed ID: 19353312 [TBL] [Abstract][Full Text] [Related]
19. Hereditary thrombophilia in ethnic Omani patients. Pathare A; Al Kindi S; Al Haddabi H; Dennison D; Bayoumi R; Muralitharan S Am J Hematol; 2006 Feb; 81(2):101-6. PubMed ID: 16432849 [TBL] [Abstract][Full Text] [Related]
20. The 19-bp deletion of dihydrofolate reductase (DHFR), methylenetetrahydrofolate reductase (MTHFR) C677T, Factor V Leiden, prothrombin G20210A polymorphisms in cancer patients with and without thrombosis. Eroglu A; Egin Y; Cam R; Akar N Ann Hematol; 2009 Jan; 88(1):73-6. PubMed ID: 18682947 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]